Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients

Inflammation Research

Volumn 56, Issue 1, 2007, Pages 32-37

  Koch, A ^a   Zacharowski, K ^a   Boehm, O ^a   Stevens, M ^a   Lipfert, P ^a   Von Giesen, H J ^b   Wolf, A ^a   Freynhagen, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Alexianer Krankenhaus   (Germany)

Author keywords

Chronic pain; Cytokines; Nitric oxide (NO); Pain intensity; Plasma concentrations

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MUSCLE RELAXANT AGENT; NITRATE; NITRIC OXIDE; NITRITE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC PAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PROTEIN BLOOD LEVEL; RATING SCALE;

ADULT; AGED; ANALGESICS; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; PAIN; PAIN MEASUREMENT; PAIN, INTRACTABLE;

EID: 33847629731     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-6088-4     Document Type: Article

References (48)

1. Riedel W, Neeck G. Nociception, pain, and antinociception: current concepts. Z Rheumatol 2001; 60(6): 404-15.
2. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52(2): 127-36.
3. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86(22): 9030-3.
4. Brenman JE, Bredt DS. Synaptic signaling by nitric oxide. Curr Opin Neurobiol 1997; 7(3): 374-8.
5. Snyder SH. Nitric oxide: first in a new class of neurotransmitters. Science 1992; 257(5069): 494-6.
6. Maihofner C, Tegeder I, Euchenhofer C, deWitt D, Brune K, Bang R et al. Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience 2000; 101(4): 1093-108.
7. Maihofner C, Euchenhofer C, Tegeder I, Beck KF, Pfeilschifter J, Geisslinger G. Regulation and immunhistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation. Neurosci Lett 2000; 290(1): 71-5.
8. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001; 90(1-2): 1-6.
9. Vikman KS, Hill RH, Backstrom E, Robertson B, Kristensson K. Interferon-gamma induces characteristics of central sensitization in spinal dorsal horn neurons in vitro. Pain 2003; 106(3): 241-51.
10. Ek M, Engblom D, Saha S, Blomqvist A, Jakobsson PJ, Ericsson-Dahlstrand A. Inflammatory response: pathway across the bloodbrain barrier. Nature 2001; 410(6827): 430-1.
11. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410(6827): 471-5.
12. Bartfai T. Immunology. Telling the brain about pain. Nature 2001; 410(6827): 425, 427.
13. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995; 2(4): 241-8.
14. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54(4): 469-87.
15. Salvemini D, Ischiropoulos H, Cuzzocrea S. Roles of nitric oxide and superoxide in inflammation. Methods Mol Biol 2003; 225: 291-303.
16. Wu J, Fang L, Lin Q, Willis WD. Fos expression is induced by increased nitric oxide release in rat spinal cord dorsal horn. Neuroscience 2000; 96(2): 351-7.
17. Lin Q, Wu J, Peng YB, Cui M, Willis WD. Nitric oxide-mediated spinal disinhibition contributes to the sensitization of primate spinothalamic tract neurons. J Neurophysiol 1999; 81(3): 1086-94.
18. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999; 96(14): 7687-92.
19. Meda L, Cassatella MA, Szendrei GI, Otvos L, Jr., Baron P, Villalba M et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995; 374(6523): 647-50.
20. Hu S, Peterson PK, Chao CC. Cytokine-mediated neuronal apoptosis. Neurochem Int 1997; 30(4-5): 427-31.
21. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004; 31(11): 2189-98.
22. Madson KL, Moore TL, Lawrence JM, III, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994; 21(12): 2359-63.
23. Gur A, Karakoc M, Nas K, Remzi, Cevik, Denli A et al. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002; 29(2): 358-61.
24. Martelletti P, Stirparo G, Giacovazzo M. Proinflammatory cytokines in cervicogenic headache. Funct Neurol 1999; 14(3): 159-62.
25. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al. Plasma cytokine levels in migraineurs and controls. Headache 2005; 45(7): 926-31.
26. Covelli V, Massari F, Fallacara C, Munno I, Pellegrino NM, Jirillo E et al. Increased spontaneous release of tumor necrosis factor-alpha/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. Int J Neurosci 1991; 61(1-2): 53-60.
27. Gratt BM, Anbar M. A pilot study of nitric oxide blood levels in patients with chronic orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100(4): 441-8.
28. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126(1): 131-8.
29. Tegeder L, Zimmermann J, Meller ST, Geisslinger G. Release of algesic substances in human experimental muscle pain. Inflamm Res 2002; 51(8): 393-402.
30. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 2001; 24(8): 450-5.
31. Wieseler-Frank J, Maier SF, Watkins LR. Central proinflammatory cytokines and pain enhancement. Neurosignals 2005; 14(4): 166-74.
32. Luo ZD, Cizkova D. The role of nitric oxide in nociception. Curr Rev Pain 2000; 4(6): 459-66.
33. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003; 23(3): 1026-40.
34. Vetter G, Geisslinger G, Tegeder I. Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain 2001; 92(1-2): 213-8.
35. Twining CM, Sloane EM, Milligan ED, Chacur M, Martin D, Poole S et al. Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats. Pain 2004; 110(1-2): 299-309.
36. Meller ST, Pechman PS, Gebhart GF, Maves TJ. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 1992; 50(1): 7-10.
37. Meller ST, Cummings CP, Traub RJ, Gebhart GF. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994; 60(2): 367-74.
38. Holthusen H, Arndt JO. Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J Physiol 1995; 487(Pt 1): 253-8.
39. Collins MP, Periquet MI. Non-systemic vasculitic neuropathy. Curr Opin Neurol 2004; 17(5): 587-98.
40. Okazaki Y, Sawada T, Nagatani K, Komagata Y, Inoue T, Muto S et al. Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol 2005; 32(8): 1440-7.
41. De Alba J, Clayton NM, Collins SD, Colthup P, Chessell I, Knowles RG. GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 2006; 120(1-2): 170-81.
42. Celerier E, Gonzalez JR, Maldonado R, Cabanero D, Puig MM. Opioid-induced Hyperalgesia in a Murine Model of Postoperative Pain: Role of Nitric Oxide Generated from the Inducible Nitric Oxide Synthase. Anesthesiology 2006; 104(3): 546-55.
43. Naik AK, Tandan SK, Kumar D, Dudhgaonkar SP. Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats. Eur J Pharmacol 2006; 530(1-2): 59-69.
44. Bolla M, Momi S, Gresele P, Del Soldato P. Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. Eur J Clin Pharmacol 2005; 1-10.
45. Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R et al. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 2000; 130(6): 1399-405.
46. Davies NM, Roseth AG, Appleyard CB, McKnight W, Del Soldato P, Calignano A et al. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther 1997; 11(1): 69-79.
47. Keeble JE, Moore PK. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 2002; 137(3): 295-310.
48. Jensen MP. Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 2006; 22(1 Suppl): S9-13.